Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Apr 1, 2014 (13 years ago)

Glytone Acne

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatment Facial Cleanser.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Glytone Acne, acne treatment facial cleanser, 2% Salicylic Acid, 200 mL/6.7 FL Oz Bottle, Distributed by Genesis Pharmaceuticals, Inc. a subsidiary of Pierre Fabre, Parsippany, NJ 07054, UPC 3 04760-00413-2

Recalling firm
Genesis Pharmaceutical, Inc.
Origin
NV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1285-2014 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other stability / shelf life recalls from 2014

All stability / shelf life recalls
Class I · High risk

MitoXANTRONE Injection

Failed Stability Specifications: Product is subpotent and has out of specification known and unknown impurities.

Terminated Stability / shelf life Hospira Inc. D-0433-2015
Class II · Moderate risk

Ticarcillin Sodium/Potassium Clavulanate

Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.

Terminated Stability / shelf life Attix Pharmaceuticals D-929-2015